share_log

关于河南羚锐制药股份有限公司2021年限制性股票激励计划第三期解锁暨上市之专项法律意见书

Special legal opinion on the unlocking of the third phase of the 2021 restricted stock incentive plan and the listing of Henan Lingrui Pharmaceutical Co., Ltd.

Sensex a share ·  Jul 22
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more